Objective:

To evaluate the predictive capability of low-coverage whole genome sequencing (lcWGS) for bowel cancer risk in patients with ulcerative colitis (UC).

Approach:

• Study Design: Analysis of 270 low-grade dysplasia samples from 122 UC patients, categorizing them as progressors or non-progressors based on the development of advanced neoplasia (AN) within five years.
• Methodology: Assessment of somatic copy number alterations (CNAs) in low-grade dysplasia lesions using lcWGS and comparison with traditional clinical risk factors.

Key Findings:

• CNA burden was significantly higher in progressors than non-progressors.
• CNA burden alone was a strong predictor of AN risk, outperforming established clinical risk factors.
• Combining genomic and clinical data improved predictive accuracy.

Interpretation:

Limitations:

• Findings need validation in larger cohorts.
• Further research required to explore feasibility of lcWGS in routine UC surveillance.

Conclusion:

Sources:

• Gut Journal
• Cancer Research UK